Chronic obstructive pulmonary disease (COPD) affects more than 24 million individuals in
the United States, although at least half of the cases are not diagnosed. Proactive diagnosis …

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality
worldwide. It is well established that patients with mild to moderate disease represent the …

COPD is progressive and typically begins many years before a definite diagnosis is made.
As the rate of decline in lung function may be faster in the initial stages of the disease, early …

Treatment guidelines are mainly based on randomised clinical trials that include a small and
highly selected fraction of the COPD population [2]. Therefore, it is questionable as to …

Chronic obstructive pulmonary disease (COPD) is a multi-faceted disease that is a major
cause of morbidity and mortality worldwide, and is a significant burden in terms of healthcare …

Preface Chronic Obstructive Pulmonary Disease (COPD) is a common disease associated
with significant morbidity and mortality that is both preventable and treatable. However, a …

There is increasing focus on understanding the nature of chronic obstructive pulmonary
disease (COPD) during the earlier stages. Mild COPD (Global Initiative for Chronic …

Aims Chronic obstructive pulmonary disease (COPD) is usually a progressive condition.
Undiagnosed early‐stage disease, particularly in symptomatic patients, is likely to become …

Chronic obstructive pulmonary disease (COPD) is a common and often progressive
inflammatory disease of the airways that is both preventable and treatable. It is well …

Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition with
considerable pathophysiological and clinical variability across patients [1]. For this reason …